Trial intelligence / Profile preview

Persistence of Major Molecular Remission in CML After a Second TKI Discontinuation

2016-004106-34Phase 2Completed

Sponsor

Akademiska sjukhuset

Start

Jan 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1